Intellia - Exciting Promise Of First In-Vivo Gene Therapy Makes Bull Case
NTLAIntellia Therapeutics(NTLA) Seeking Alpha·2024-09-26 04:40

If you like what you have just read and want to receive at least 4 exclusive stock tips every week focused on Pharma, Biotech and Healthcare, then join me at my marketplace channel, Haggerston BioHealth . Invest alongside the model portfolio or simply access the investment bank-grade financial models and research. I hope to see you there.Intellia Therapeutics (NASDAQ: NTLA ) is one of the vanguard of companies that is attempting to convert the amazing and Nobel Prize winning technology of CRISPR/Cas9 into c ...